「hete」に関連した英語例文の一覧と使い方 - Weblio英語例文検索

To obtain a drug capable of inhibiting a 20-hexaeicosatetraenoic acid (20-HETE)-producing enzyme associated with microvascular vasoconstriction, vasodilator, cell growth eliciting actions, etc., in main organs such as the kidney, cerebral blood vessels, etc.例文帳に追加

腎臓、脳血管等の主要臓器における微小血管収縮、拡張作用、細胞増殖惹起作用等に関与している２０−ＨＥＴＥの産生酵素を阻害する薬剤を提供すること。 - 特許庁

To provide an agent inhibiting 20-HETE production enzyme participating in the constricting and dilating action of microvessels of principal organs such as kidney and cerebral vessel, cell proliferation inducing action, etc.例文帳に追加

腎臓、脳血管等の主要臓器における微小血管収縮、拡張作用、細胞増殖惹起作用等に関与している２０−ＨＥＴＥの産生酵素を阻害する薬剤を提供すること。 - 特許庁

To provide a medicine for inhibiting an enzyme for producing 20-HETE, associated with vasoconstrictive or vasodilating action of microvasculature and action of causing cell proliferation, and the like, in main internal organs such as the kidney and the cerebral blood vessel.例文帳に追加

腎臓、脳血管等の主要臓器における微小血管収縮、拡張作用、細胞増殖惹起作用等に関与している２０−ＨＥＴＥの産生酵素を阻害する薬剤を提供すること。 - 特許庁

This phenylpyrazole derivative expressed by formula (1) and its salts, the method for producing the compounds, the anti-oxidative medicine containing the compounds, and the treating agent of the renal diseases, etc., inhibitor of the oxidative disorder of the retina, lipoxygenase inhibitor and 20-HETE synthase inhibitor containing the anti-oxidative medicine are provided.例文帳に追加

式（１）で表されるフェニルピラゾール誘導体又はその塩、この化合物の製造方法、この化合物を含む抗酸化薬、該抗酸化薬を含む、腎疾患等の治療薬、網膜の酸化障害の抑制薬、リポキシゲナーゼ阻害薬、及び２０−ＨＥＴＥシンターゼ阻害薬。 - 特許庁

To provide a new phenylpyrazole derivative or salts of the same, a method for producing the compounds, an anti-oxidative medicine containing the compounds and a treating agent of renal diseases, cerebrovascular diseases, cardiovascular diseases and cerebral infarction, an inhibitor of an oxidative disorder of retina, a lipoxygenase inhibitor and a 20-HETE synthase inhibitor containing the anti-oxidative medicine.例文帳に追加

新規なフェニルピラゾール誘導体又はその塩、この化合物の製造方法、この化合物を含む抗酸化薬、並びに該抗酸化薬を含む、腎疾患、脳血管疾患、循環器疾患、脳梗塞の治療薬、網膜の酸化障害の抑制薬、リポキシゲナーゼ阻害薬、及び２０−ＨＥＴＥシンターゼ阻害薬の提供。 - 特許庁